| Article

A narrative review of minocycline—a 2nd-generation, semi-synthetic tetracycline used as a broad-spectrum antibiotic with anti-inflammatory properties—was performed by researchers evaluating its effectiveness in lessening neuropathic pain. Results were published in the Journal of Pain Research. A...

| Article

Cancer leads to chronic pain for 5 million cancer survivors, and that pain is frequently treated with medication. However, acupuncture treatments may work better, and with fewer potential side effects. An article in JAMA Oncology reports a review of two types of acupuncture: electroacupuncture...

| Article

Chemotherapy-induced neuropathic pain (CINP) is seen in up to 70% of cancer patients. Unfortunately, there is no effective treatment, and CINP causes many people to terminate their chemotherapy treatments. In a study published in the Journal of Pain Research, mice were separated into 4 test groups...

| Article

Radiation therapy vs an injection. A patient with bone cancer may need about 10 sessions of radiation therapy, but a new radioactive bone cement is proving to be easier on the patient, and safer. Brachytherapy is a local treatment during which a radiation source is placed in or near the tumor. With...

| Article

As stated in the abstract of an article in JCO Clinical Cancer Informatics, a journal of the American Society of Clinical Oncology, “Approximately 40% of childhood cancer survivors experience chronic pain, with many also reporting pain-related disability. Given associations established in the...

| Article

In the journal Nature Machine Intelligence, a new article states, “Colonoscopy is limited by the outdated design of conventional endoscopes, which are associated with high complexity of use, cost and pain.” There are 19,000,000 procedures done each year in the United States and European Union, with...

| Article

Two scientists from the New York University College of Dentistry have received a grant of $3,900,000 to research potential targets of chronic pain. Over the next 5 years, endosomal receptors will be studied with the aim of improving the management of pain, and using fewer—or no—opioids. The...

| Article

Newswise — The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, has awarded NYU College of Dentistry’s Yi Ye, PhD, a $2.2 million, five-year grant to study the role of Schwann cells, the most prevalent type of cell supporting neurons in the...

| Article

Koselugo (selumetinib) has received the first approval for treatment of neurofibromatosis type 1 (NF1) in children ages 2 years and older, the U.S. Food and Drug Administration announced Friday.

Approved specifically for patients with symptomatic, inoperable plexiform neurofibromas (PNs)...

| Article

Newswise — NIBIB-funded bioengineers at the University of Illinois have combined standard microscopy, infrared light, and artificial intelligence (AI) to assemble digital biopsies that identify important molecular characteristics of cancer biopsy samples without dyes or labels.

The standard...

Subscribe to cancer

Sign-Up